secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001193125-25-179382
Event type: regulatory
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics updates Nasdaq listing; panel grants continued listing with conditions
--------------------------------------------------------------------------------

- Nasdaq panel granted continued listing; must demonstrate $2.5M stockholders' equity compliance by Aug 14, 2025.
- Must also meet $1.00 bid price for 10 consecutive days by Sep 8, 2025.
- Company reported stockholders' deficit of $23.6M as of March 31, 2025, triggering delisting notice.
- Hearing held July 15, 2025; panel decision issued July 22, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525179382/0001193125-25-179382-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525179382/d930191d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-179382

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer